Elucid, which provides AI-based imaging software for heart disease, raised $80 million in Series C funding, CEO Blake Richards tells Axios exclusively.
Why it matters: In the U.S., heart disease is the leading cause of death, and cardiology care is the single largest driver of health care spending — giving developers of lower-cost and preventive interventions ample opportunity to innovate.
